Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
Domestic business was up 41.9% YoY and 27.7% QoQ
Anti-malaria API facility will be operational in 15-18 months
Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis Tablets, 800 mg/26.6 mg
In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace
The govt has rolled out three schemes for promoting the manufacture of API
Turnover of API division of ISLL stood at Rs 856.58 crore
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
The company confirms an upward revision to its 2021 Outlook, reflecting the expectation to achieve mid-teens CER sales growth
Subscribe To Our Newsletter & Stay Updated